Accel Research Sites - St. Pete-Largo Clinical Research Unit — Largo, Florida

Accel Research Sites - St. Pete-Largo Clinical Research Unit is a clinical research site located in Largo, Florida, United States 33777.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Accel Research Sites - St. Pete-Largo Clinical Research Unit has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Alzheimer Disease, Type 2 Diabetes Mellitus, RSV Infection.

Sponsors: Eli Lilly and Company, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Largo

Browse all research sites in Florida · View every site in Largo

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accel Research Sites - St. Pete-Largo Clinical Research Unit?

Accel Research Sites - St. Pete-Largo Clinical Research Unit has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accel Research Sites - St. Pete-Largo Clinical Research Unit conducted?

Accel Research Sites - St. Pete-Largo Clinical Research Unit has 4 clinical trials on record, with 1 currently active. Their work covers Alzheimer Disease, Type 2 Diabetes Mellitus, RSV Infection.

Is Accel Research Sites - St. Pete-Largo Clinical Research Unit accredited by Crixeo Clinical Trials?

Accel Research Sites - St. Pete-Largo Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accel Research Sites - St. Pete-Largo Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.